Company Search:
Advanced Search
Sponsored Links
TaiMed Biologics Inc Company Snapshot
TaiMed Biologics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares TaiMed Biologics Inc with three other companies in this sector in TAIWAN : Medigen Biotechnology Corporation (2019 sales of 552.35 million Taiwanese Dollars [US$18.48 million] of which 66% was Drug Discovery), Sunmax Biotechnology Co Limited (594.15 million Taiwanese Dollars [US$19.87 million] of which 84% was China Mainland), and Sofiva Genomics Co Ltd (509.45 million Taiwanese Dollars [US$17.04 million] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
TaiMed Biologics Inc
  Stock Performance Chart for TaiMed Biologics Inc
  Stock Data: Recent Stock Performance:
  Current Price (5/29/2020): 94.50
(Figures in Taiwanese Dollars )
1 Week 0.9%   13 Weeks -2.5%  
4 Weeks 6.2%   52 Weeks -32.0%  
TaiMed Biologics Inc Key Data:
  Ticker: 4147 Country: Taiwan
  Exchanges: TAI Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 704,504,000
(Year Ending Jan 2020).
Employees: 23
  Currency: Taiwanese Dollars Market Cap: 23,832,711,000
  Fiscal Yr Ends: December Shares Outstanding: 252,198,000
  Share Type: Gu Closely Held Shares: 84,362,000
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.